Caption Management, LLC Biotechnology

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ACLX
Arcellx, Inc.
PUT
$43.4 Million
520K
Q3 2024
New holding
ARGX
Argenx Se
CALL
$35.7 Million
65.8K
Q2 2024
New holding
INSM
Insmed Inc
PUT
$31.1 Million
427K
Q3 2024
New holding
ARGX
Argenx Se
PUT
$25.5 Million
47.1K
Q2 2024
New holding
VRTX
Vertex Pharmaceuticals Inc
CALL
$23.3 Million
50K
Q1 2024
New holding
EWTX
Edgewise Therapeutics, Inc.
CALL
$21.9 Million
820K N/A
PCVX
Vaxcyte, Inc.
CALL
$20 Million
175K
Q3 2024
New holding
ACLX
Arcellx, Inc.
CALL
$18 Million
216K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
CALL
$17 Million
590K
Q3 2024
Reduced 49.77%
VKTX
Viking Therapeutics, Inc.
CALL
$16.4 Million
258K
Q3 2024
Reduced 8.16%
AGIO
Agios Pharmaceuticals, Inc.
PUT
$13.3 Million
300K
Q3 2024
New holding
BGNE
Bei Gene, Ltd.
CALL
$13.2 Million
58.9K
Q4 2022
Added 144.64%
CAPR
Capricor Therapeutics, Inc.
CALL
$12.4 Million
813K N/A
CLDX
Celldex Therapeutics, Inc.
CALL
$11.9 Million
350K
Q3 2024
New holding
CYTK
Cytokinetics Inc
PUT
$10.2 Million
193K
Q3 2024
Reduced 50.0%
RYTM
Rhythm Pharmaceuticals, Inc.
CALL
$10 Million
191K
Q2 2024
New holding
TARS
Tarsus Pharmaceuticals, Inc.
CALL
$9.87 Million
300K N/A
BPMC
Blueprint Medicines Corp
CALL
$9.32 Million
101K
Q4 2023
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$8.77 Million
576K N/A
IMVT
Immunovant, Inc.
CALL
$8.09 Million
294K
Q3 2024
Added 347.26%
FULC
Fulcrum Therapeutics, Inc.
CALL
$7.9 Million
2.21M
Q3 2024
Reduced 41.48%
NVO
Novo Nordisk A S
CALL
$7.7 Million
64.7K
Q3 2024
New holding
BBIO
Bridge Bio Pharma, Inc.
CALL
$7.42 Million
291K
Q3 2024
Reduced 85.22%
NUVL
Nuvalent, Inc.
CALL
$7.4 Million
72.3K N/A
BBIO
Bridge Bio Pharma, Inc.
PUT
$7.39 Million
290K
Q3 2024
Reduced 85.22%
CYTK
Cytokinetics Inc
CALL
$7.06 Million
134K
Q3 2024
Reduced 50.0%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$6.85 Million
24.9K
Q3 2024
Reduced 95.07%
INSM
Insmed Inc
CALL
$6.77 Million
92.8K
Q3 2024
New holding
KRYS
Krystal Biotech, Inc.
CALL
$6.55 Million
36K
Q3 2023
New holding
NUVL
Nuvalent, Inc.
PUT
$6.51 Million
63.6K N/A
SNDX
Syndax Pharmaceuticals Inc
PUT
$5.04 Million
262K
Q3 2024
New holding
PCVX
Vaxcyte, Inc.
PUT
$5.02 Million
44K
Q3 2024
New holding
SRPT
Sarepta Therapeutics, Inc.
PUT
$5 Million
40K
Q3 2024
Reduced 87.63%
ASND
Ascendis Pharma A/S
CALL
$4.85 Million
32.5K
Q2 2024
Reduced 51.2%
VRDN
Viridian Therapeutics, Inc.\De
PUT
$4.79 Million
210K
Q2 2024
Added 77.2%
IONS
Ionis Pharmaceuticals Inc
CALL
$4.69 Million
117K
Q3 2024
Reduced 83.38%
VRDN
Viridian Therapeutics, Inc.\De
CALL
$4.37 Million
192K
Q2 2024
Added 77.2%
FULC
Fulcrum Therapeutics, Inc.
PUT
$4.3 Million
1.2M
Q3 2024
Reduced 41.48%
CORT
Corcept Therapeutics Inc
PUT
$4.16 Million
90K
Q1 2024
New holding
EXEL
Exelixis, Inc.
PUT
$4.14 Million
159K
Q3 2024
Added 122.43%
SRPT
Sarepta Therapeutics, Inc.
CALL
$4.06 Million
32.5K
Q3 2024
Reduced 87.63%
PTGX
Protagonist Therapeutics, Inc
PUT
$4.01 Million
89.2K
Q3 2024
New holding
MIRM
Mirum Pharmaceuticals, Inc.
CALL
$3.88 Million
99.5K N/A
KRYS
Krystal Biotech, Inc.
PUT
$3.64 Million
20K
Q3 2023
New holding
ARVN
Arvinas, Inc.
PUT
$3.54 Million
144K
Q1 2022
Added 2900.0%
ETNB
89bio, Inc.
PUT
$3.44 Million
466K
Q2 2024
Added 81.01%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$3.34 Million
30K
Q2 2022
Closed
CORT
Corcept Therapeutics Inc
CALL
$3.24 Million
70K
Q1 2024
New holding
MRNA
Moderna, Inc.
PUT
$3.21 Million
48K
Q4 2022
New holding
Filter Shares Options
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email